PLX038 in Brain and Spinal Cord Tumors
Phase 1/2
120
about 9.8 years
18–120
1 site in MD
What this study is about
This trial is testing a treatment called PLX038 in people with certain types of brain or spinal cord tumors. The goal is to see if this drug can help these patients. Participants will have tests done, including imaging scans and blood work, before starting the treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take PLX038
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Determine overall survival (OS), Determine progression free survival (PFS), Longitudinally evaluate patient reported outcomes (PRO)
Oncology